FLGT

24.1202.66%
MN

Michael Nohaile

Independent Non-Employee Director

Dr. Michael Nohaile, also known as Mike, Ph.D., serves as Chief Executive Officer at Prellis Biologics, Inc. since August 2022 and serves as its Director. He serves as Non-Employee Director of Fulgent Genetics, Inc. since August 01, 2022. He serves as Business Advisor of Juvena Therapeutics, Inc. He was the Chief Scientific Officer of Generate Biomedicines. Prior to joining Generate, Dr. Nohaile held several roles of increasing responsibility at Amgen Inc., where he was Senior Vice President of Strategy, Commercialization and Innovation. Dr. Nohaile joined Amgen as Vice President of Strategy in December 2012. He has deep industry experience and expertise in leveraging innovative technologies for therapeutic discovery and development. Prior to Amgen, Dr. Nohaile was at Novartis AG in Switzerland where he was Global Head and General Manager of Molecular Diagnostics. He served Novartis as the Head of Corporate Strategy and Head of Pharmaceutical Strategy. He began his career at McKinsey & Company, where he was a Partner and worked extensively in healthcare with a focus on diagnostics, devices and pharmaceuticals. Dr. Nohaile received his Ph. D. in Molecular and Cell Biology from the University of California, Berkeley and completed his postdoctoral fellowship at the Massachusetts Institute of Technology (MIT) in the Department of Biology. He received his undergraduate degrees in Chemistry and Life Science from MIT.

Positions